Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Tuberculosis Diagnostics Revenue 1.4 Market Analysis by Type 1.4.1 Global Tuberculosis Diagnostics Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Culture-based 1.4.3 Sputum Smear Microscopy 1.4.4 Rapid Molecular 1.4.5 Others 1.5 Market by Application 1.5.1 Global Tuberculosis Diagnostics Market Share by Application: 2020 VS 2026 1.5.2 Hospital 1.5.3 Diagnostic Laboratories 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Tuberculosis Diagnostics Market Perspective (2015-2026) 2.2 Tuberculosis Diagnostics Growth Trends by Regions 2.2.1 Tuberculosis Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Tuberculosis Diagnostics Historic Market Share by Regions (2015-2020) 2.2.3 Tuberculosis Diagnostics Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Tuberculosis Diagnostics Market Growth Strategy 2.3.6 Primary Interviews with Key Tuberculosis Diagnostics Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Tuberculosis Diagnostics Players by Market Size 3.1.1 Global Top Tuberculosis Diagnostics Players by Revenue (2015-2020) 3.1.2 Global Tuberculosis Diagnostics Revenue Market Share by Players (2015-2020) 3.1.3 Global Tuberculosis Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Tuberculosis Diagnostics Market Concentration Ratio 3.2.1 Global Tuberculosis Diagnostics Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Tuberculosis Diagnostics Revenue in 2019 3.3 Tuberculosis Diagnostics Key Players Head office and Area Served 3.4 Key Players Tuberculosis Diagnostics Product Solution and Service 3.5 Date of Enter into Tuberculosis Diagnostics Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Tuberculosis Diagnostics Historic Market Size by Type (2015-2020) 4.2 Global Tuberculosis Diagnostics Forecasted Market Size by Type (2021-2026) 5 Tuberculosis Diagnostics Breakdown Data by Application (2015-2026) 5.1 Global Tuberculosis Diagnostics Market Size by Application (2015-2020) 5.2 Global Tuberculosis Diagnostics Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Tuberculosis Diagnostics Market Size (2015-2020) 6.2 Tuberculosis Diagnostics Key Players in North America (2019-2020) 6.3 North America Tuberculosis Diagnostics Market Size by Type (2015-2020) 6.4 North America Tuberculosis Diagnostics Market Size by Application (2015-2020) 7 Europe 7.1 Europe Tuberculosis Diagnostics Market Size (2015-2020) 7.2 Tuberculosis Diagnostics Key Players in Europe (2019-2020) 7.3 Europe Tuberculosis Diagnostics Market Size by Type (2015-2020) 7.4 Europe Tuberculosis Diagnostics Market Size by Application (2015-2020) 8 China 8.1 China Tuberculosis Diagnostics Market Size (2015-2020) 8.2 Tuberculosis Diagnostics Key Players in China (2019-2020) 8.3 China Tuberculosis Diagnostics Market Size by Type (2015-2020) 8.4 China Tuberculosis Diagnostics Market Size by Application (2015-2020) 9 Japan 9.1 Japan Tuberculosis Diagnostics Market Size (2015-2020) 9.2 Tuberculosis Diagnostics Key Players in Japan (2019-2020) 9.3 Japan Tuberculosis Diagnostics Market Size by Type (2015-2020) 9.4 Japan Tuberculosis Diagnostics Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Tuberculosis Diagnostics Market Size (2015-2020) 10.2 Tuberculosis Diagnostics Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Tuberculosis Diagnostics Market Size by Type (2015-2020) 10.4 Southeast Asia Tuberculosis Diagnostics Market Size by Application (2015-2020) 11 India 11.1 India Tuberculosis Diagnostics Market Size (2015-2020) 11.2 Tuberculosis Diagnostics Key Players in India (2019-2020) 11.3 India Tuberculosis Diagnostics Market Size by Type (2015-2020) 11.4 India Tuberculosis Diagnostics Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Tuberculosis Diagnostics Market Size (2015-2020) 12.2 Tuberculosis Diagnostics Key Players in Central & South America (2019-2020) 12.3 Central & South America Tuberculosis Diagnostics Market Size by Type (2015-2020) 12.4 Central & South America Tuberculosis Diagnostics Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Danaher 13.1.1 Danaher Company Details 13.1.2 Danaher Business Overview and Its Total Revenue 13.1.3 Danaher Tuberculosis Diagnostics Introduction 13.1.4 Danaher Revenue in Tuberculosis Diagnostics Business (2015-2020)) 13.1.5 Danaher Recent Development 13.2 Roche 13.2.1 Roche Company Details 13.2.2 Roche Business Overview and Its Total Revenue 13.2.3 Roche Tuberculosis Diagnostics Introduction 13.2.4 Roche Revenue in Tuberculosis Diagnostics Business (2015-2020) 13.2.5 Roche Recent Development 13.3 Thermo Fisher Scientific 13.3.1 Thermo Fisher Scientific Company Details 13.3.2 Thermo Fisher Scientific Business Overview and Its Total Revenue 13.3.3 Thermo Fisher Scientific Tuberculosis Diagnostics Introduction 13.3.4 Thermo Fisher Scientific Revenue in Tuberculosis Diagnostics Business (2015-2020) 13.3.5 Thermo Fisher Scientific Recent Development 13.4 BD 13.4.1 BD Company Details 13.4.2 BD Business Overview and Its Total Revenue 13.4.3 BD Tuberculosis Diagnostics Introduction 13.4.4 BD Revenue in Tuberculosis Diagnostics Business (2015-2020) 13.4.5 BD Recent Development 13.5 Abbott 13.5.1 Abbott Company Details 13.5.2 Abbott Business Overview and Its Total Revenue 13.5.3 Abbott Tuberculosis Diagnostics Introduction 13.5.4 Abbott Revenue in Tuberculosis Diagnostics Business (2015-2020) 13.5.5 Abbott Recent Development 13.6 Hologic 13.6.1 Hologic Company Details 13.6.2 Hologic Business Overview and Its Total Revenue 13.6.3 Hologic Tuberculosis Diagnostics Introduction 13.6.4 Hologic Revenue in Tuberculosis Diagnostics Business (2015-2020) 13.6.5 Hologic Recent Development 13.7 Qiagen 13.7.1 Qiagen Company Details 13.7.2 Qiagen Business Overview and Its Total Revenue 13.7.3 Qiagen Tuberculosis Diagnostics Introduction 13.7.4 Qiagen Revenue in Tuberculosis Diagnostics Business (2015-2020) 13.7.5 Qiagen Recent Development 13.8 BioMerieux 13.8.1 BioMerieux Company Details 13.8.2 BioMerieux Business Overview and Its Total Revenue 13.8.3 BioMerieux Tuberculosis Diagnostics Introduction 13.8.4 BioMerieux Revenue in Tuberculosis Diagnostics Business (2015-2020) 13.8.5 BioMerieux Recent Development 13.9 Hain Lifescience 13.9.1 Hain Lifescience Company Details 13.9.2 Hain Lifescience Business Overview and Its Total Revenue 13.9.3 Hain Lifescience Tuberculosis Diagnostics Introduction 13.9.4 Hain Lifescience Revenue in Tuberculosis Diagnostics Business (2015-2020) 13.9.5 Hain Lifescience Recent Development 13.10 Oxford Immunotec 13.10.1 Oxford Immunotec Company Details 13.10.2 Oxford Immunotec Business Overview and Its Total Revenue 13.10.3 Oxford Immunotec Tuberculosis Diagnostics Introduction 13.10.4 Oxford Immunotec Revenue in Tuberculosis Diagnostics Business (2015-2020) 13.10.5 Oxford Immunotec Recent Development 13.11 Epistem 10.11.1 Epistem Company Details 10.11.2 Epistem Business Overview and Its Total Revenue 10.11.3 Epistem Tuberculosis Diagnostics Introduction 10.11.4 Epistem Revenue in Tuberculosis Diagnostics Business (2015-2020) 10.11.5 Epistem Recent Development 13.12 Akonni Biosystems 10.12.1 Akonni Biosystems Company Details 10.12.2 Akonni Biosystems Business Overview and Its Total Revenue 10.12.3 Akonni Biosystems Tuberculosis Diagnostics Introduction 10.12.4 Akonni Biosystems Revenue in Tuberculosis Diagnostics Business (2015-2020) 10.12.5 Akonni Biosystems Recent Development 13.13 Creative Diagnostics 10.13.1 Creative Diagnostics Company Details 10.13.2 Creative Diagnostics Business Overview and Its Total Revenue 10.13.3 Creative Diagnostics Tuberculosis Diagnostics Introduction 10.13.4 Creative Diagnostics Revenue in Tuberculosis Diagnostics Business (2015-2020) 10.13.5 Creative Diagnostics Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Tuberculosis Diagnostics Key Market Segments Table 2. Key Players Covered: Ranking by Tuberculosis Diagnostics Revenue Table 3. Ranking of Global Top Tuberculosis Diagnostics Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Tuberculosis Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Culture-based Table 6. Key Players of Sputum Smear Microscopy Table 7. Key Players of Rapid Molecular Table 8. Key Players of Others Table 9. Global Tuberculosis Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 10. Global Tuberculosis Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026 Table 11. Global Tuberculosis Diagnostics Market Size by Regions (2015-2020) (US$ Million) Table 12. Global Tuberculosis Diagnostics Market Share by Regions (2015-2020) Table 13. Global Tuberculosis Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 14. Global Tuberculosis Diagnostics Market Share by Regions (2021-2026) Table 15. Market Top Trends Table 16. Key Drivers: Impact Analysis Table 17. Key Challenges Table 18. Tuberculosis Diagnostics Market Growth Strategy Table 19. Main Points Interviewed from Key Tuberculosis Diagnostics Players Table 20. Global Tuberculosis Diagnostics Revenue by Players (2015-2020) (Million US$) Table 21. Global Tuberculosis Diagnostics Market Share by Players (2015-2020) Table 22. Global Top Tuberculosis Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Diagnostics as of 2019) Table 23. Global Tuberculosis Diagnostics by Players Market Concentration Ratio (CR5 and HHI) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Tuberculosis Diagnostics Product Solution and Service Table 26. Date of Enter into Tuberculosis Diagnostics Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Tuberculosis Diagnostics Market Size by Type (2015-2020) (Million US$) Table 29. Global Tuberculosis Diagnostics Market Size Share by Type (2015-2020) Table 30. Global Tuberculosis Diagnostics Revenue Market Share by Type (2021-2026) Table 31. Global Tuberculosis Diagnostics Market Size Share by Application (2015-2020) Table 32. Global Tuberculosis Diagnostics Market Size by Application (2015-2020) (Million US$) Table 33. Global Tuberculosis Diagnostics Market Size Share by Application (2021-2026) Table 34. North America Key Players Tuberculosis Diagnostics Revenue (2019-2020) (Million US$) Table 35. North America Key Players Tuberculosis Diagnostics Market Share (2019-2020) Table 36. North America Tuberculosis Diagnostics Market Size by Type (2015-2020) (Million US$) Table 37. North America Tuberculosis Diagnostics Market Share by Type (2015-2020) Table 38. North America Tuberculosis Diagnostics Market Size by Application (2015-2020) (Million US$) Table 39. North America Tuberculosis Diagnostics Market Share by Application (2015-2020) Table 40. Europe Key Players Tuberculosis Diagnostics Revenue (2019-2020) (Million US$) Table 41. Europe Key Players Tuberculosis Diagnostics Market Share (2019-2020) Table 42. Europe Tuberculosis Diagnostics Market Size by Type (2015-2020) (Million US$) Table 43. Europe Tuberculosis Diagnostics Market Share by Type (2015-2020) Table 44. Europe Tuberculosis Diagnostics Market Size by Application (2015-2020) (Million US$) Table 45. Europe Tuberculosis Diagnostics Market Share by Application (2015-2020) Table 46. China Key Players Tuberculosis Diagnostics Revenue (2019-2020) (Million US$) Table 47. China Key Players Tuberculosis Diagnostics Market Share (2019-2020) Table 48. China Tuberculosis Diagnostics Market Size by Type (2015-2020) (Million US$) Table 49. China Tuberculosis Diagnostics Market Share by Type (2015-2020) Table 50. China Tuberculosis Diagnostics Market Size by Application (2015-2020) (Million US$) Table 51. China Tuberculosis Diagnostics Market Share by Application (2015-2020) Table 52. Japan Key Players Tuberculosis Diagnostics Revenue (2019-2020) (Million US$) Table 53. Japan Key Players Tuberculosis Diagnostics Market Share (2019-2020) Table 54. Japan Tuberculosis Diagnostics Market Size by Type (2015-2020) (Million US$) Table 55. Japan Tuberculosis Diagnostics Market Share by Type (2015-2020) Table 56. Japan Tuberculosis Diagnostics Market Size by Application (2015-2020) (Million US$) Table 57. Japan Tuberculosis Diagnostics Market Share by Application (2015-2020) Table 58. Southeast Asia Key Players Tuberculosis Diagnostics Revenue (2019-2020) (Million US$) Table 59. Southeast Asia Key Players Tuberculosis Diagnostics Market Share (2019-2020) Table 60. Southeast Asia Tuberculosis Diagnostics Market Size by Type (2015-2020) (Million US$) Table 61. Southeast Asia Tuberculosis Diagnostics Market Share by Type (2015-2020) Table 62. Southeast Asia Tuberculosis Diagnostics Market Size by Application (2015-2020) (Million US$) Table 63. Southeast Asia Tuberculosis Diagnostics Market Share by Application (2015-2020) Table 64. India Key Players Tuberculosis Diagnostics Revenue (2019-2020) (Million US$) Table 65. India Key Players Tuberculosis Diagnostics Market Share (2019-2020) Table 66. India Tuberculosis Diagnostics Market Size by Type (2015-2020) (Million US$) Table 67. India Tuberculosis Diagnostics Market Share by Type (2015-2020) Table 68. India Tuberculosis Diagnostics Market Size by Application (2015-2020) (Million US$) Table 69. India Tuberculosis Diagnostics Market Share by Application (2015-2020) Table 70. Central & South America Key Players Tuberculosis Diagnostics Revenue (2019-2020) (Million US$) Table 71. Central & South America Key Players Tuberculosis Diagnostics Market Share (2019-2020) Table 72. Central & South America Tuberculosis Diagnostics Market Size by Type (2015-2020) (Million US$) Table 73. Central & South America Tuberculosis Diagnostics Market Share by Type (2015-2020) Table 74. Central & South America Tuberculosis Diagnostics Market Size by Application (2015-2020) (Million US$) Table 75. Central & South America Tuberculosis Diagnostics Market Share by Application (2015-2020) Table 76. Danaher Company Details Table 77. Danaher Business Overview Table 78. Danaher Product Table 79. Danaher Revenue in Tuberculosis Diagnostics Business (2015-2020) (Million US$) Table 80. Danaher Recent Development Table 81. Roche Company Details Table 82. Roche Business Overview Table 83. Roche Product Table 84. Roche Revenue in Tuberculosis Diagnostics Business (2015-2020) (Million US$) Table 85. Roche Recent Development Table 86. Thermo Fisher Scientific Company Details Table 87. Thermo Fisher Scientific Business Overview Table 88. Thermo Fisher Scientific Product Table 89. Thermo Fisher Scientific Revenue in Tuberculosis Diagnostics Business (2015-2020) (Million US$) Table 90. Thermo Fisher Scientific Recent Development Table 91. BD Company Details Table 92. BD Business Overview Table 93. BD Product Table 94. BD Revenue in Tuberculosis Diagnostics Business (2015-2020) (Million US$) Table 95. BD Recent Development Table 96. Abbott Company Details Table 97. Abbott Business Overview Table 98. Abbott Product Table 99. Abbott Revenue in Tuberculosis Diagnostics Business (2015-2020) (Million US$) Table 100. Abbott Recent Development Table 101. Hologic Company Details Table 102. Hologic Business Overview Table 103. Hologic Product Table 104. Hologic Revenue in Tuberculosis Diagnostics Business (2015-2020) (Million US$) Table 105. Hologic Recent Development Table 106. Qiagen Company Details Table 107. Qiagen Business Overview Table 108. Qiagen Product Table 109. Qiagen Revenue in Tuberculosis Diagnostics Business (2015-2020) (Million US$) Table 110. Qiagen Recent Development Table 111. BioMerieux Business Overview Table 112. BioMerieux Product Table 113. BioMerieux Company Details Table 114. BioMerieux Revenue in Tuberculosis Diagnostics Business (2015-2020) (Million US$) Table 115. BioMerieux Recent Development Table 116. Hain Lifescience Company Details Table 117. Hain Lifescience Business Overview Table 118. Hain Lifescience Product Table 119. Hain Lifescience Revenue in Tuberculosis Diagnostics Business (2015-2020) (Million US$) Table 120. Hain Lifescience Recent Development Table 121. Oxford Immunotec Company Details Table 122. Oxford Immunotec Business Overview Table 123. Oxford Immunotec Product Table 124. Oxford Immunotec Revenue in Tuberculosis Diagnostics Business (2015-2020) (Million US$) Table 125. Oxford Immunotec Recent Development Table 126. Epistem Company Details Table 127. Epistem Business Overview Table 128. Epistem Product Table 129. Epistem Revenue in Tuberculosis Diagnostics Business (2015-2020) (Million US$) Table 130. Epistem Recent Development Table 131. Akonni Biosystems Company Details Table 132. Akonni Biosystems Business Overview Table 133. Akonni Biosystems Product Table 134. Akonni Biosystems Revenue in Tuberculosis Diagnostics Business (2015-2020) (Million US$) Table 135. Akonni Biosystems Recent Development Table 136. Creative Diagnostics Company Details Table 137. Creative Diagnostics Business Overview Table 138. Creative Diagnostics Product Table 139. Creative Diagnostics Revenue in Tuberculosis Diagnostics Business (2015-2020) (Million US$) Table 140. Creative Diagnostics Recent Development Table 141. Research Programs/Design for This Report Table 142. Key Data Information from Secondary Sources Table 143. Key Data Information from Primary Sources List of Figures Figure 1. Global Tuberculosis Diagnostics Market Share by Type: 2020 VS 2026 Figure 2. Culture-based Features Figure 3. Sputum Smear Microscopy Features Figure 4. Rapid Molecular Features Figure 5. Others Features Figure 6. Global Tuberculosis Diagnostics Market Share by Application: 2020 VS 2026 Figure 7. Hospital Case Studies Figure 8. Diagnostic Laboratories Case Studies Figure 9. Others Case Studies Figure 10. Tuberculosis Diagnostics Report Years Considered Figure 11. Global Tuberculosis Diagnostics Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Tuberculosis Diagnostics Market Share by Regions: 2020 VS 2026 Figure 13. Global Tuberculosis Diagnostics Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Tuberculosis Diagnostics Market Share by Players in 2019 Figure 16. Global Top Tuberculosis Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Diagnostics as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Tuberculosis Diagnostics Revenue in 2019 Figure 18. North America Tuberculosis Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Tuberculosis Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 20. China Tuberculosis Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Japan Tuberculosis Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Southeast Asia Tuberculosis Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 23. India Tuberculosis Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Central & South America Tuberculosis Diagnostics Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Danaher Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Danaher Revenue Growth Rate in Tuberculosis Diagnostics Business (2015-2020) Figure 27. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Roche Revenue Growth Rate in Tuberculosis Diagnostics Business (2015-2020) Figure 29. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Thermo Fisher Scientific Revenue Growth Rate in Tuberculosis Diagnostics Business (2015-2020) Figure 31. BD Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. BD Revenue Growth Rate in Tuberculosis Diagnostics Business (2015-2020) Figure 33. Abbott Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Abbott Revenue Growth Rate in Tuberculosis Diagnostics Business (2015-2020) Figure 35. Hologic Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Hologic Revenue Growth Rate in Tuberculosis Diagnostics Business (2015-2020) Figure 37. Qiagen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Qiagen Revenue Growth Rate in Tuberculosis Diagnostics Business (2015-2020) Figure 39. BioMerieux Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. BioMerieux Revenue Growth Rate in Tuberculosis Diagnostics Business (2015-2020) Figure 41. Hain Lifescience Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Hain Lifescience Revenue Growth Rate in Tuberculosis Diagnostics Business (2015-2020) Figure 43. Oxford Immunotec Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Oxford Immunotec Revenue Growth Rate in Tuberculosis Diagnostics Business (2015-2020) Figure 45. Epistem Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. Epistem Revenue Growth Rate in Tuberculosis Diagnostics Business (2015-2020) Figure 47. Akonni Biosystems Total Revenue (US$ Million): 2019 Compared with 2018 Figure 48. Akonni Biosystems Revenue Growth Rate in Tuberculosis Diagnostics Business (2015-2020) Figure 49. Creative Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 50. Creative Diagnostics Revenue Growth Rate in Tuberculosis Diagnostics Business (2015-2020) Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Danaher Roche Thermo Fisher Scientific BD Abbott Hologic Qiagen BioMerieux Hain Lifescience Oxford Immunotec Epistem Akonni Biosystems Creative Diagnostics